Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors Slides
PDF | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
All of the information necessary to understanding the CAP/IASLC/AMP guideline in one downloadable PDF. Includes comparison to the 2013 version.
Powered By